Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion
NASDAQ:AIFC

ALT5 Sigma 5/18/2026 Earnings Report

ALT5 Sigma logo
$0.86 -0.05 (-5.32%)
As of 05/19/2026 03:57 PM Eastern

ALT5 Sigma EPS Results

Actual EPS
-$2.14
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ALT5 Sigma Revenue Results

Actual Revenue
$4.71 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

ALT5 Sigma Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

ALT5 Sigma Earnings Headlines

AIFC AI Financial Corporation
ALT5 Sigma (NASDAQ:AIFC) Shares Down 4.8% - What's Next?
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement.tc pixel
See More ALT5 Sigma Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ALT5 Sigma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ALT5 Sigma and other key companies, straight to your email.

About ALT5 Sigma

ALT5 Sigma (NASDAQ:AIFC) Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.

View ALT5 Sigma Profile